Home > Financial Ratios > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 28.3213.968.0318.19-3.74

What is the latest Core EBITDA Growth ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 28.32 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202528.32
Mar202413.96
Mar20238.03
Mar202218.19
Mar2021-3.74

How is Core EBITDA Growth of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 28.32
102.87
Mar2024 13.96
73.85
Mar2023 8.03
-55.85
Mar2022 18.19
Positive
Mar2021 -3.74 -

Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹38,522.4 Cr -5% -10.3% 10.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,905.0 Cr -5.2% -7.6% -8.6% Stock Analytics
DIVIS LABORATORIES ₹159,357.0 Cr -5.6% -7.3% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,788.0 Cr -0.6% 4.8% 25% Stock Analytics
CIPLA ₹110,628.0 Cr -4.5% -9.7% -4.6% Stock Analytics
DR REDDYS LABORATORIES ₹96,441.5 Cr -2.6% -9.7% -10.5% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-5%

-10.3%

10.6%

SENSEX

-2.1%

-3%

6.8%


You may also like the below Video Courses